What kind of stocks stir up controversy like no other? Penny stocks.
Of all the controversial plays on Wall Street, penny stocks take the cake. The risk-tolerant flock to these names as the potential for …
Over the last month, shares of micro-cap biotech Agile Therapeutics (AGRX) have crashed by an alarming 55%. Following such a remarkable decline, you …
Global investment bank, RBC Capital, is one of the finance world’s heavy hitters. It is the 5th largest in North America, and with …
Agile therapeutics (AGRX) has had a, shall we say, crazy week in the market. On Monday, October 28, its share price was sent …
Shares of Agile Therapeutics (AGRX), a biotech which specializes in women’s healthcare, are in a nose dive, down about 66% in the past …
Along with healthcare stocks in general, biotechnology stocks are not hitting any near-term highs in terms of share price performance. Chalk it up …
Most biotech stocks have been under pressure recently, but as we approach the end of the year, many analysts are quite bullish as …
At just $68 million in market capitalization, Agile Therapeutics (AGRX) is anything but what you’d call “Big Pharma” — but it’s getting bigger. …
Even though Cantor’s William Tanner slices his price target, he nonetheless angles for almost 115% whopping upside potential for AGRX shares.
